0001437749-21-014028.txt : 20210603 0001437749-21-014028.hdr.sgml : 20210603 20210603084102 ACCESSION NUMBER: 0001437749-21-014028 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210419 FILED AS OF DATE: 20210603 DATE AS OF CHANGE: 20210603 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Byrne Joseph A. CENTRAL INDEX KEY: 0001736911 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-55557 FILM NUMBER: 21991306 MAIL ADDRESS: STREET 1: 6 CAMERON SIDE ROAD EAST CITY: ESSEX STATE: A6 ZIP: N8M 2X5 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CEN BIOTECH INC CENTRAL INDEX KEY: 0001653821 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: Z4 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 300-3295 QUALITY WAY CITY: WINDSOR STATE: A6 ZIP: N8T 3R9 BUSINESS PHONE: 226-344-0660 MAIL ADDRESS: STREET 1: 300-3295 QUALITY WAY CITY: WINDSOR STATE: A6 ZIP: N8T 3R9 3 1 rdgdoc.xml FORM 3 X0206 3 2021-04-19 0 0001653821 CEN BIOTECH INC CENBF 0001736911 Byrne Joseph A. 300-3295 QUALITY WAY WINDSOR, ONTARIO, CANADA A6 N8T 3R9 ONTARIO, CANADA 1 1 President Common Stock 1364894 D Common Stock 164000 I By Spouse Common Stock 1.6000 2016-08-17 2020-08-17 Common Stock 76123 D Joseph Byrne (the "Reporting Person") was appointed to his positions with CEN Biotech, Inc. (the "Issuer") on April 19, 2021 and owned 1,362,894 shares of the Issuer's common stock at such date. The Reporting Person also beneficially owns a convertible note with 76,123 shares issuable upon conversion of same. /s/ Joseph Byrne 2021-06-03